Please assess the completion status of the following clinical trial:

Trial Title: Electrotherapy in the Management of Myofascial Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female who had first breast cancer surgery, regardless of the type of surgery~* Age ≥ 18 years~* Patients with refractory pain with myofascial syndrome, with a numerical scale ≥ 4~* Topical treatment for refractory pain completed more than 30 days ago~* Healthy, non-irritated skin on painful areas to treat~* Patient with a third party who can attend visits M0 and M2.5~* Obtaining the signed written consent of the patient~* Major patient affiliated to a social security scheme~Exclusion Criteria:~* Patient who has used TENS before on the muscles affected by the myofascial syndrome~* Post-surgery management of the affected area by a physiotherapist~* Person with venous thrombosis~* Contraindications specific to the treatments studied

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- TENS / TENS ECOMODYN (Type: OTHER): Patients who have signed their consent receive, after randomization, the trial treatments assigned to them. Arm TENS / TENS ECOMODYN Patients first start with TENS during 2 months puis change with TENS ECOMODYN during 2 months with a wash-out period of 15 days
- TENS ECOMODYN / TENS (Type: OTHER): Patients who have signed their consent receive, after randomization, the trial treatments assigned to them. Arm TENS ECOMODYN / TENS Patients first start with TENS ECOMODYN during 2 months puis change with TENS during 2 months with a wash-out period of 15 days

Based on this trial design, predict the completion outcome and termination type (if applicable).